Dosimetric feasibility study ("proof of concept") of refractory ventricular tachycardia radioablation using proton minibeams

CONCLUSION: This proof-of-concept study shows that proton minibeam radiotherapy can achieve a homogeneous coverage of an arrhythmogenic cardiac zone, reducing the dose at the normal tissues. This technique, ensuring could theoretically reduce the risk of late pulmonary and breast fibrosis, as well as cardiac toxicity as seen in previous biological studies in proton minibeam radiotherapy.PMID:38599941 | DOI:10.1016/j.canrad.2024.02.002

Source: Cancer Radiotherapie - April 10, 2024 Category: Cancer & Oncology Authors: P Loap M Giorgi J Vu-Bezin K Kirov J M Sampai Y Prezado Y Kirova Source Type: research